Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$16.26 - $21.73 $2,097 - $2,803
-129 Reduced 99.23%
1 $0
Q4 2022

Feb 06, 2023

SELL
$16.98 - $23.15 $696 - $949
-41 Reduced 23.98%
130 $2,000
Q2 2022

Jul 19, 2022

SELL
$17.07 - $25.71 $2,304 - $3,470
-135 Reduced 44.12%
171 $3,000
Q1 2022

Apr 29, 2022

BUY
$20.42 - $28.13 $2,348 - $3,234
115 Added 60.21%
306 $7,000
Q4 2021

Jan 24, 2022

SELL
$25.89 - $33.45 $854 - $1,103
-33 Reduced 14.73%
191 $5,000
Q3 2021

Oct 29, 2021

BUY
$22.46 - $29.47 $3,009 - $3,948
134 Added 148.89%
224 $6,000
Q2 2021

Aug 02, 2021

SELL
$24.17 - $36.01 $459 - $684
-19 Reduced 17.43%
90 $3,000
Q1 2021

Apr 29, 2021

BUY
$32.28 - $44.3 $3,518 - $4,828
109 New
109 $4,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.4B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.